170 related articles for article (PubMed ID: 32866908)
1. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of multiparametric MRI parameters for Gleason score and cellularity metrics of prostate cancer in different zones: a quantitative comparison.
Gao J; Zhang Q; Zhang C; Chen M; Li D; Fu Y; Lv X; Zhang B; Guo H
Clin Radiol; 2019 Nov; 74(11):895.e17-895.e26. PubMed ID: 31337490
[TBL] [Abstract][Full Text] [Related]
3. Association of prostate zonal volume with location and aggressiveness of clinically significant prostate cancer: A multiparametric MRI study according to PI-RADS version 2.1.
Yang L; Li M; Zhang MN; Yao J; Song B
Eur J Radiol; 2022 May; 150():110268. PubMed ID: 35344914
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone.
Lee H; Hwang SI; Lee HJ; Byun SS; Lee SE; Hong SK
PLoS One; 2018; 13(6):e0199636. PubMed ID: 29933396
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.
Afshari Mirak S; Mohammadian Bajgiran A; Sung K; Asvadi NH; Markovic D; Felker ER; Lu D; Sisk A; Reiter RE; Raman SS
Abdom Radiol (NY); 2020 Jul; 45(7):2225-2234. PubMed ID: 31549211
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
[TBL] [Abstract][Full Text] [Related]
8. Shape Analysis of Peripheral Zone Observations on Prostate DWI: Correlation to Histopathology Outcomes After Radical Prostatectomy.
Abreu-Gomez J; Wu M; McInnes MDF; Thornhill RE; Flood TA; Schieda N
AJR Am J Roentgenol; 2020 Jun; 214(6):1239-1247. PubMed ID: 32228325
[No Abstract] [Full Text] [Related]
9. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
[TBL] [Abstract][Full Text] [Related]
10. Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images.
Fehr D; Veeraraghavan H; Wibmer A; Gondo T; Matsumoto K; Vargas HA; Sala E; Hricak H; Deasy JO
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6265-73. PubMed ID: 26578786
[TBL] [Abstract][Full Text] [Related]
11. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones.
Gaudiano C; Bianchi L; Corcioni B; Giunchi F; Schiavina R; Ciccarese F; Braccischi L; Rustici A; Fiorentino M; Brunocilla E; Golfieri R
Int Urol Nephrol; 2022 Feb; 54(2):263-271. PubMed ID: 34822065
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Quantification of Water Diffusion, Stiffness, and Tissue Fluidity in Benign Prostatic Hyperplasia and Prostate Cancer.
Asbach P; Ro SR; Aldoj N; Snellings J; Reiter R; Lenk J; Köhlitz T; Haas M; Guo J; Hamm B; Braun J; Sack I
Invest Radiol; 2020 Aug; 55(8):524-530. PubMed ID: 32496317
[TBL] [Abstract][Full Text] [Related]
14. Automatic Detection of Prostate Tumor Habitats using Diffusion MRI.
Tschudi Y; Pollack A; Punnen S; Ford JC; Chang YC; Soodana-Prakash N; Breto AL; Kwon D; Munera F; Abramowitz MC; Kryvenko ON; Stoyanova R
Sci Rep; 2018 Nov; 8(1):16801. PubMed ID: 30429515
[TBL] [Abstract][Full Text] [Related]
15. Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score.
Donati OF; Afaq A; Vargas HA; Mazaheri Y; Zheng J; Moskowitz CS; Hricak H; Akin O
Clin Cancer Res; 2014 Jul; 20(14):3705-11. PubMed ID: 24850842
[TBL] [Abstract][Full Text] [Related]
16. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
17. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
[TBL] [Abstract][Full Text] [Related]
18. Prostate heterogeneity correlates with clinical features on multiparametric MRI.
Chen C; Yang Z; Sweeney E; Hectors SJ; Hu JC; Margolis DJ
Abdom Radiol (NY); 2021 Nov; 46(11):5369-5376. PubMed ID: 34292363
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.
Glazer DI; Hassanzadeh E; Fedorov A; Olubiyi OI; Goldberger SS; Penzkofer T; Flood TA; Masry P; Mulkern RV; Hirsch MS; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2017 Mar; 42(3):918-925. PubMed ID: 27770164
[TBL] [Abstract][Full Text] [Related]
20. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.
Wibmer A; Hricak H; Gondo T; Matsumoto K; Veeraraghavan H; Fehr D; Zheng J; Goldman D; Moskowitz C; Fine SW; Reuter VE; Eastham J; Sala E; Vargas HA
Eur Radiol; 2015 Oct; 25(10):2840-50. PubMed ID: 25991476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
